Life Sciences

Strategic Transaction
Advisory

Your specialist Life Sciences M&A, Corporate Finance and Capital Sourcing firm

Looking for Life Sciences and Healthcare experts?

Get in touch

Vinc supports Life Sciences companies with strategic consulting and corporate finance advisory services, throughout their entire business cycle. All the way from start-up, via company growth to succession and exit.

Get in touch

Creative strategic advice, persistent execution

Approach

Vinc was created in order to help companies active in the Life Sciences industry execute transformational transactions. Through all phases: pre-transaction, transaction, post-transaction. From start-ups to international corporations. With a 100% Life Sciences focus and our dedication to solution orientation, we speak the same language as our clients and act not only as service provider, we become a sparring partner.

Combining independent strategy consulting and financial advisory – Strategic Transaction Advisory.

Customers from all over the world trust our competence in managing the sale and acquisition of companies, products and product portfolios, strategic advice, structuring financings and executing licensing as well as royalty monetization transactions. And we’re there for them, wherever they need us.

We’re really blessed to have found VincAdvisory, as a specialist Life Sciences M&A advisory firm for our European acquisition initiatives. Due to their industry specialization, they immediately understood our business, quickly familiarized themselves with our company and acquisition strategy and helped us in identifying and speaking to the right fit targets. Their entrenchment within the industry and their relationships with small- and medium sized company owners and owner families is unparalleled. Being headquartered in the US, this has been truly helpful to SPX Flow.

Vusa Mlingo
VP Corporate Development & Strategy – SPX FLOW, US

We have been in contact with Thomas and Vinc for more than 5 years, ever since he pro-actively reached out to us. Since then, he has been our gateway to the pharma CRO industry in Europe and our one-stop shop to understand the pharma CRO industry, to identify potential opportunities, to increase our scale and to run the M&A process. Thomas and his team combine a deep knowledge & network with a creative & entrepreneurial mindset to come up with innovative constellations.

Koen de Witte
CEO and Shareholder - reMYND, BE

It was a pleasure working with the teamof Vinc - on the other side(!). Vinc is a very professional organization within-depth industry expertise – top league for mid-market transactions – and haveclearly helped the sellers in the best way.

Gijs Botman
Managing Partner - Mentha Capital, NL

Full range of strategic advisory services for transformational transactions

Services

With Vinc’s holistic advisory approach, we excel in tailor-made and solution oriented project execution, helping our clients to overcome their most challenging issues.

M&A Advisory

Vinc is a leading advisor in sale and carve-out preparation, exit readiness, commercial DD, company and plant sales and acquisitions, joint ventures and strategic alliances, post-merger strategy, buy&build and divestments.

Financial Advisory

We help our clients with tailor-made financial structuring, valuation and fairness opinions, defense strategies, debt financings, equity capital market transactions, project financings, recapitalizations, fundraisings.

Product Advisory

Vinc executes international pre-commercial and commercial-stage licensing transactions, product and product portfolio sales and acquisitions, R&D/patent sales and acquisitions, as well as royalty monetization transactions.

Committee Advisory

We provide independent, special advisory services to company management, shareholders and executive committees with respect to value creation topics, M&A strategies, growth and market entry strategies as well as shareholder relations.

Produkte

Company Sale
+

Company Sale

  • Full fledge sell-side advisory
  • Optional Modules
          Valuation project
          Market Sounding
  • Across all scenarios: Succession, Carve-out, PE-Exit, Crossborder/International, Best-fit buyers
EXIT Preparation
+

EXIT Preparation

  • Best practice approach customized with company owner
  • Focus on Sale and Succession preparation 
  • Building Equity Story and create robustness for future due diligence
CEO Sparring
+

CEO Sparring

  • Outside-in perspective and independent party
  • Trust, Industry Knowledge and Market Insights 
  • “Safe space” to challenge and develop the most relevant strategic topics 
Turbocharged Investment Assessment
+

Turbocharged Investment Assessment

  • Business Model, Products, Operational, Technical, Commercial, Regulatory – focussed vs. 360°
  • Investment Committee Language Readiness, Equity Story Conviction
  • Pre-Transaction: Pre-Assessment and beefing up C-Suite “Coffee Chats”
  • Start Due Diligence: Accelerated Red-Flag Analysis and Snapshot, Guidance for further DD, Risk Mitigation Plan
  • End of Due Diligence: Deep Dive-Cross Check on Specific Questions, 2nd opinion on specific topics, IC recommendation
Buyside Actionability
+

Buyside Actionability

  • Industry focussed AI powered target sourcing
  • Strategic M&A routes and associated pros/cons
  • Acquisition Strategy and Add-on Analysis
  • Structured Buyside Process
Manufacturing Network Evaluation
+

Manufacturing Network Evaluation

  • Footprint analysis
  • Fit with long term manufacturing needs
  • Competitiveness
  • Versatility
  • Exploration of strategic options (carve out, manufacturing partnership, investments etc.)

Full range of strategic advisory services for transformational transactions

Case studies

Our Team has extensive deal-making experience, deep sector knowledge and strong personal relationships with the key decision makers in the Life Sciences industry. Combined with our passion, dedication and determination we’re able to provide a particular value-add for your project and/or transaction.

Asset Evaluation and Carve-Out
+

Asset Evaluation and Carve-Out

  • Identification and evaluation of best-fit partner
  • Cross-Cultural “Moderator”
  • Deal Structuring and Negotiations
  • Momentum kept in Covid crisis peak
Targeted Acquisition (BE, ES, UK)
+

Targeted Acquisition (BE, ES, UK)

  • Private Equity backed buy&build add-on
  • Technology focussed, best-fit target company identification
  • Cross-border project management and high-speed transaction execution
  • 4 weeks from first contact to signing
C-Suite Sparring (DE)
+

C-Suite Sparring (DE)

  • Evaluation of strategic options 
  • Development of (flexible) company presentation for external communication
  • Business Plan and roadmap going forward

Company Sale (CH, DE, NL)
+

Company Sale (CH, DE, NL)

  • Exclusive sell-side mandate and process execution 
  • Complex exit and transaction structure with numerous sellers
  • Transition from Venture Capital to Private Equity

In-depth expertise accross the convergent Life Sciences industry landscape – from molecule to market

Expertise

Vinc’s unparalleled specialization and long-standing expertise lies particularly within the businesses along the pharmaceutical development chain; besides that, we’re advising clients in the MedTech, Diagnostics and Digital Health space.

Pharma, Biotech and Life Sciences Outsourcing and Contracting Services

  • API
  • Contract Research
  • Clinical Research
  • C(D)MO
  • Drug Delivery
  • Filling & Packaging
  • Lab Services
  • Logistics Services
  • Reg./Quality Consulting
  • Sales/Marketing

Pharma, Biotech and Life Sciences Product Business

  • Biotech
  • Branded Pharma
  • Generics
  • Nutraceuticals
  • Other Life Sciences

We, repeatedly, have been working with Vinc Advisory as they are a real expert consulting organization for the pharma and pharma services industry – and with them combining extensive corporate finance know-how with a strong track record and access to all necessary functional experts in assessing business opportunities, they are able to provide preeminent advice for making our investment decisions. Beyond transaction tactics and deal structuring, they have been supporting us in quickly gaining a comprehensive understanding of business models, quality of technological and service offerings, uncovering hidden value potentials as well as potential risk factors from a financial, operational and strategic point of view. They have been a great sparring partner in various M&A projects and it has been always a pleasure working with the Vinc team.

Frank Rotmann
Co-Founder - pharma&, CH

We experienced Vinc as extremely knowledgeable and professional. When it comes to Life Sciences, their deep sector expertise and global network is a real asset and unusually broad for an M&A firm of their size; we were positively surprised. They also did a great job for the sellers where they had to manage conflicting interests of various parties involved within a very short time period. We look forward to working with them in the future.

Alexander Zamora
Partner - Capiton, DE

We were very pleased with the support from Vinc during the entire process of the sale of our business. We really welcome the opportunity of the GBA Laboratory Group moving the company forward to the next stages of its growth. Vinc has done a great job. Many thanks for getting what we believe was the best outcome of this transaction.

Dr. Christine Batzl-Hartmann
CEO and founder - Pharmacelsus, DE

I would like to truly express my appreciation for VINC Advisory. They provided invaluable support in helping to position the company for future growth and opportunities, increasing value for its shareholders.
Throughout their outstanding experience in the life science and health care sectors they provided keen counsel and identification in the market of the most suitable technology and industrial partner that shall help the company to achieve its ambitious goals and further increase its value.

Head of Engineering
Multinational Pharmaceutical/Biotech Company, EU

The Vinc Team has been one of the very few amongst the advisory firms to demonstrate an intimate understanding of our CDMO industry, thus clearly standing out. Their expertise is clear and precious and their approach is professional and pragmatic, clearly going the extra mile to bring value.

Head of Corporate Development
Top 10 Drug Product CDMO, EU

Dedicated Advisory Team focussed exclusively on the Life Sciences industry

Team

Our Team has extensive deal-making experience, deep sector knowledge and strong personal relationships with the key decision makers in the Life Sciences industry. Combined with our passion, dedication and determination we’re able to provide a particular value-add for your project and/or transaction.

+
Manfred Stadler
Partner

Manfred Stadler

Partner
General  Transaction & Financial Advisory Lead

Manfred has M&A, Management, Finance and Controlling expertise; Life Sciences and API Experience in Corporate Strategy and M&A, Head of BD and CFO roles. He has lived and worked in various countries (US, UK, CH, D, A) and industries (Pharma, Chemical, Communications) and gathered both, management and consulting  experience and skills. His deep understanding of the industry, of valuing and integrating businesses, makes him a valuable partner in transaction and transformation processes.

Previously:  Kybora, Cambrex, Lonza, DDB, Mobil Oil

+
Thomas Kern
Founder and Managing Partner

Thomas Kern

Founder and Managing Partner
General  Transaction & Financial Advisory Lead

Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his clients. Building bridges between company owners and investors, constructing compelling equity stories, deal moderation and negotiation are his speciality.

Previously: Citi, Deutsche Bank, MP Corporate Finance

+
Stephan Freudl
Partner

Stephan Freudl

Partner
General  Transaction & Financial Advisory Lead

Stephan  is a successful investor, advisor and mentor, strongly rooted within the Life Sciences industry. He is also Co-Founder of VINC Growth. His clients and ventures benefit both, from his large network and long-standing experience gained in numerous transactions and investments. Developing and executing the right “Road-to- EXIT” strategy, growth financing & capital sourcing and structuring business models are his speciality.

Previously: Deutsche Bank, LonVin Partners (Founder), SEF Opportunities Group (Founder)

+
Giuseppe Cassisi
Partner

Giuseppe Cassisi

Partner
General  Transaction & Financial Advisory Lead

Giuseppe has substantial experience in top level strategic management positions in the Life Science industry. He excells in sales and business development, as well as global business management. He gained his extraordinary skills in the domestic (Italian) and international markets. Giuseppe combines a deep understanding of the Life Sciences industry with a deep understanding and vision on how the industry will evolve.

Previously:  Polpharma, Doppel Farmaceutici, Patheon, Pharmatec Int'l

+
Jon Nighswander
Partner

Jon Nighswander

Partner
General  Transaction & Financial Advisory Lead

Jon is a successful executive, investor, and advisor with a global track record of  achievement in the medical device industry. He has led numerous organizations “from good to great” and has extensive experience both, sourcing and closing transactions. Jon specializes in special situations, valuations, corporate transformation, post-merger  integration and transaction support.

Previously:  PwC, FTI, EMSA Capital, Schottentor Capital (Founder)

+
Dietmar Hofstätter
Partner

Dietmar Hofstätter

Partner
General  Transaction & Financial Advisory Lead

Dietmar is an independent consultant in the life science sector, specialized in in- and out-licensing, as well as business and corporate development. With his extensive top-level management experience, he has a extremely wide network in virtually every country of the world. Combining his  PhD in law with in-depth pharmaceutical knowledge, Dietmar excels in transforming business models with well balanced, workable and understandable contracts.

Previously:  Asta Medica (now: Mylan), Lederle (now: Pfizer), Sandoz

+
Hervé Mouneyrac
Partner

Hervé Mouneyrac

Partner
General  Transaction & Financial Advisory Lead

Hervé has extensive CDMO expertise, with particular focus on strategy and value creation, corporate acquisition and integration processes, as well as business development and cost reduction initiatives. He has had a transforming impact in CDMO on an international scale. With his creative and pragmatic problem solving skills he generates competitive advantage for his clients, defining a vision and aligning the organization to deliver it, thanks to his deep understanding of the industry.

Previously:  Famar, Masai, Renault

Experts

Our Team has extensive deal-making experience, deep sector knowledge and strong personal relationships with the key decision makers in the Life Sciences industry. Combined with our passion, dedication and determination we’re able to provide a particular value-add for your project and/or transaction.

Fabio D’Agostino
Cell and Gene Therapy
Fabio D’Agostino Copy
Cell and Gene Therapy
Fabio D’Agostino Copy 5
Cell and Gene Therapy
Fabio D’Agostino Copy 4
Cell and Gene Therapy
Fabio D’Agostino Copy 2
Cell and Gene Therapy
Fabio D’Agostino Copy 3
Cell and Gene Therapy
Fabio D’Agostino
Cell and Gene Therapy
Fabio D’Agostino Copy
Cell and Gene Therapy
Fabio D’Agostino Copy 2
Cell and Gene Therapy
Fabio D’Agostino Copy 4
Cell and Gene Therapy
Fabio D’Agostino Copy 3
Cell and Gene Therapy
Fabio D’Agostino Copy 5
Cell and Gene Therapy

Full range of strategic advisory services for transformational transactions

Our Value-Add

  • Focused on overall corporate strategy
  • Pragmatism, speed, solution-orientation and discretion
  • Comprehensive and committed Buy-Side execution
  • Access to solution providers for divestments
  • Special committee advisory – cut to the chase
  • Exclusive life sciences industry focus for an unobstructed view
  • Tailor-made and solution-oriented
    project execution
  • Patience and adjusted to your
    pace in finding the right partner
  • Focused on executing strategies
    rather than “only” a transaction
  • Shield for emotions
  • Clear and dedicated industry focus
  • Mediator between investors and entrepreneurs
  • Acquisition strategy and structured Buy-Side advice instead of „Lucky Shots“
  • Exit strategy as well as pre- and post-transaction advice
  • Highest quality IB services for mid-market transactions
  • Deep industry entrenchment to find the right sparring partner/target
  • Strategic advisory support
  • Hands-on and solution oriented approach
  • Management interruption at min. level and negotiation power at max. level
  • Assertive negotiation on your behalf to avoid jeopardizing future relationships

We Are a Society. Bringing Together Smart, Entrepreneurial, Experienced, and Passionate People

Culture

Inclusive

We offer opportunities within
our society to everyone.

People-oriented

We believe in the power of
network and people.

Open-minded

Think outside the box.

Beyond Zeitgeist

We live in the future guided
by our purpose.

Passion

We believe only passion
makes one exceptional and
ensures businesses
flourishes. And, being
passionate ourselves, we
push the limits and improve
constantly.

Get in touch with us

Contact

We like to listen and to understand. And we’re happy to discuss your specific case and to share our ideas – hands-on, pragmatic, concise. Here’s how you can reach us:

VINC Advisory GmbH
Life Sciences Strategic Transaction Advisory
Rathausstrasse 11
1010 Vienna, Austria

hello@vincadvisory.com
+43 1 361 66 63-0

VIENNA – PARIS – MILAN – DUBAI - NEW YORK

Legal info
Privacy policy